Lifeline Biotech ( LLBT LLBO)

[b0bd0le]

RealPennies: Alerts: Turning Pennies into dollars: (OTCPK: LBTN)
11:03 AM ET - M2

RealPennies.com ALERTS: reporting on dollar volume movers.

--

--


For information on LBTN: http://www.realpennies.com/indepth/look.php?company=LBTN .

Lifeline Biotechnologies, Inc. closed at $.0002 Tuesday, trading 271,094,469 shares.

Lifeline Biotechnologies, Inc. (OTCPK: LBTN) announced yesterday that its Neural Network Classification of breast cancer with blind temperature screening is no longer a myth but a fact.

According to Louis Keith, MD, PhD, Lifeline Biotechnologies, Medical Director and Vice President, "Predicting the future with Artificial Intelligence has always been a hit or miss proposition. Predictions have been made on computers whose functional capacities were limited but ever increasing. This means, in practical terms, that yesterday's predictions, however good, became out of date with the next generation of computers." Jim Holmes, Lifeline's CEO, stated, "After almost three years of investigation, an entirely new neural network has been developed, which has become the basis of a new Lifeline patent application on thermal interpretation. Our system had been under trained. We had the correct ideas with Artificial Intelligence, but we had no idea that we had not pushed our system to its ultimate limits. Lifeline Biotechnologies is now on the right path. These new results are soon to appear in a major peer review medical journal."

About Lifeline Biotechnologies, Inc. (OTCPK: LBTN)

Lifeline Biotechnologies, Inc. is a company with innovative medical technologies committed to the improvement of the quality of life through exceptional health care systems. These technologies focus on prevention, early detection, diagnosis and quick recovery of a number of disease conditions. The company's technologies, designed to assist in the early detection of cancers, deal with cutting-edge innovation to assist practicing physicians in the delivery of quality medical care.